The History and Future of Ablative Neurosurgery for Major Depressive Disorder
Authors:
- Peter GiacobbePGPeter Giacobbe
- G. Rees CosgroveGCG. Rees Cosgrove
- Anthony LevittALAnthony Levitt
- Andres M. LozanoALAndres M. Lozano
- Nir LipsmanNLNir Lipsman
- 20 July 2017
- journal article
- review article
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 95 (4) , 216-228
Abstract
Background: There is an urgent need to develop safe and effective treatments for patients with treatment-resistant depression (TRD). Several neurosurgical procedures have been developed to treat the dysfunctional brain circuits implicated in major depression. Objectives: This review describes the most common ablative procedures used to treat major depressive disorder: anterior cingulotomy, subcaudate tractotomy, limbic leucotomy, and anterior capsulotomy. The efficacy and safety of each are discussed and compared with other current and emerging modalities, including deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS). Methods: The PubMed and MEDLINE electronic databases were used in this study, through July 2016. Keywords, including “treatment resistant depression,” and “ablative neurosurgery,” etc. were used to generate reference hits. Results: Approximately a third to half of patients who underwent ablative procedures achieved a treatment response and/or remission. The efficacy and safety profiles corresponding to both ablative procedures and DBS were very similar. Conclusions: The longitudinal experience with ablative procedures shows that there remains an important role for accurate, discrete lesions in disrupting affective circuitry in the treatment of TRD. New modalities, such as MRgFUS, have the potential to further improve the accuracy of ablative procedures, while enhancing safety by obviating the need for open brain surgery.Keywords
This publication has 63 references indexed in Scilit:
- The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)The Journal of Clinical Psychiatry, 2015
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013Psychiatric Services, 2014
- Surgery for Psychiatric DisordersWorld Neurosurgery, 2013
- The Economic Burden of Treatment-Resistant DepressionClinical Therapeutics, 2013
- Neurostimulatory and ablative treatment options in major depressive disorder: a systematic reviewActa Neurochirurgica, 2010
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.Journal of Affective Disorders, 2009
- Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experienceMolecular Psychiatry, 2008
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005